Literature DB >> 10423631

Alprostadil: modes of actions in peripheral arterial occlusive disease.

D Karetova1, J Bultas, V Vondracek, M Aschermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 10423631

Source DB:  PubMed          Journal:  Am J Ther        ISSN： 1075-2765            Impact factor:   2.688


× No keyword cloud information.
  3 in total

1.  The effect of prostaglandin E1 on brainstem blood flow disturbance in an animal model of vertebrobasilar insufficiency.

Authors:  Toshiaki Yamanaka; Takayuki Murai; Yachiyo Sawai; Hideyuki Okamoto; Hiroshi Hosoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

2.  In Vivo Targeted Metabolomic Profiling of Prostanit, a Novel Anti-PAD NO-Donating Alprostadil-Based Drug.

Authors:  Ksenia M Shestakova; Natalia E Moskaleva; Natalia V Mesonzhnik; Alexey V Kukharenko; Igor V Serkov; Igor I Lyubimov; Elena V Fomina-Ageeva; Vladimir V Bezuglov; Mikhail G Akimov; Svetlana A Appolonova
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411

3.  Therapeutic effects of carbogen inhalation and lipo-prostaglandin E1 in sudden hearing loss.

Authors:  Hyun-Jin Lee; Chong Yoon Park; Jae Heon Lee; Hoon-Shik Yang; Joo Hyun Kim; Myung Jin Ban; In Seok Moon
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.